At Factorial, we are committed to making single-cell sequencing accessible to all researchers. Our team of experienced scientists brings a wealth of knowledge, dedication, and passion for expanding the frontiers of what’s possible with single-cell sequencing and enabling access for all.
©2024 Factorial Biotechnologies. All rights reserved.
Founder & CEO
John is the CEO of Factorial Biotechnologies, which he founded in 2020. Prior to Factorial, John was Director of Bioinformatics and System Integration at Agilent Technologies. John joined Agilent as part of their acquisition of Lasergen, where he was an early employee. At Lasergen, John led software, hardware and strategic collaborations.
Hunter works at the intersection of molecular biology, chemistry and engineering. Prior to Factorial, Hunter led sequencing operations, experimental design and assay development at Sangamo Therapeutics and UC Berkeley. Hunter completed his Ph.D. Molecular and Cellular Biology at Baylor College of Medicine.
